US Stock MarketDetailed Quotes
RAIN Rain Oncology
Watchlist
1.260
+0.150+13.51% Close 06/02 16:00 ET
1.240-0.020-1.59%
Post 19:59 ET
1.379High1.200Low7.43MVolume
1.240Open1.110Pre Close9.47MTurnover108.60%Turnover RatioLossP/E (TTM)45.82MMarket Cap14.48052wk HighLossP/E (Static)36.36MShares0.94052wk Low0.48P/B8.62MFloat Cap23.900Historical High--Dividend TTM6.84MShs Float0.940Historical Low--Div YieldTTM16.12%Amplitude1.274Avg Price1Lot Size
Company Profile
Symbol
RAIN
Company Name
Rain Oncology
Listing Date
04/23/2021
Founded
2017
CEO
Mr. Avanish Vellanki
Market
NASDAQ
Employees
63
Securities Type
Ordinary Shares
Fiscal Year Ends
12-31
Address
8000 Jarvis Avenue,Suite 204
City
Newark
Province
California
Country
United States of America
Zip Code
94560
Phone
1-510-953-5559
Website
http://www.rainoncology.comDescription
Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA.
Company Executives
No Data